Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine

Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy

On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy

The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy

Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer

Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

Current State of Dendritic Cell-Based Immunotherapy: Opportunities for Antigen Loading of Different DC Subsets?

Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage